Doxifluridine promotes host longevity through bacterial metabolism.
Aging is associated with alternative splicing (AS) defects that have broad implications on aging-associated disorders. However, which drug(s) can rescue age-related AS defects and extend lifespan has not been systematically explored. We performed large-scale compound screening in C. elegans using a...
| Published in: | PLoS Genetics |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-03-01
|
| Online Access: | https://doi.org/10.1371/journal.pgen.1011648 |
